Breaking News

Global Biologics Contract Manufacturing Market Forecasted to Grow

Expected to expand at a CAGR of ~9% during the forecast period from 2023 to 2035.

Author Image

By: Charlie Sternberg

Associate Editor

According to a recent report by ResearchAndMarkets, the global biologics contract manufacturing market (also known as the biopharmaceutical CMO market) was valued at over $19 billion in 2023 and is expected to grow at a CAGR of ~9% between 2023 and 2035 to $55.97 billion.   Drawing insights from various parameters, anticipated adoption trends, and validated through primary research, the report aims to offer an informed estimate of the market’s evolution throughout the forecast period fro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters